Bausch & Lomb | Bausch Health | Virginia | state | 2023 | $300,000 | | grant |
Novozymes Blair, Inc. | Novo Holdings A/S | Nebraska | state | 2023 | $475,775 | | tax rebate |
Genentech Inc | Roche | Oregon | local | 2023 | $3,134,511 | | property tax abatement |
Intervet Inc. | Merck | Kansas | state | 2022 | undisclosed | | tax credit/rebate |
Safc Biosciences | Merck KGaA (EMD) | Kansas | state | 2022 | undisclosed | | tax credit/rebate |
Zoetis, LLC | Zoetis | Nebraska | state | 2022 | $789,317 | | tax rebate |
Astrazeneca Pharmaceuticals, Lp | AstraZeneca | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Gilead Sciences, Inc. & Subsidiaries | Gilead Sciences | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Novavax, Inc. | Novavax Inc. | Maryland | state | 2022 | $250,000 | | tax credit/rebate |
Emergent Biosolutions Inc. And Subsidiaries | Emergent BioSolutions | Maryland | state | 2022 | $130,702 | | tax credit/rebate |
Otsuka America, Inc. & Subsidiaries | Otsuka Pharmaceutical | Maryland | state | 2022 | $57,678 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2022 | $34,500 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2022 | $21,412 | | tax credit/rebate |
Janssen Research & Development | Johnson & Johnson | Maryland | state | 2022 | $19,167 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2022 | $0 | $800,000 | grant/loan hybrid program |
St. Jude Medical | Abbott Laboratories | Minnesota | state | 2022 | undisclosed | | sales tax exemption |
Regeneron Pharmaceuticals, Inc. (MH#2) | Regeneron Pharmaceuticals | New York | state | 2022 | $5,000,000 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. (MH#3) | Regeneron Pharmaceuticals | New York | state | 2022 | $2,500,000 | | tax credit/rebate |
Pharmavite LLC | Otsuka Pharmaceutical | Ohio | state | 2022 | $2,080,000 | | tax credit/rebate |
Alcami Carolinas Corporation | Alcami | South Carolina | state | 2022 | undisclosed | | grant |
Eli Lilly and Company II | Eli Lilly | North Carolina | state | 2022 | $16,169,000 | | grant |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2022 | $200,152 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2022 | $12,182 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2022 | $4,871 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $47,494 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | North Carolina | state | 2022 | $18,821 | | tax credit/rebate |
Pfizer Research (NC), Inc. | Pfizer | North Carolina | state | 2022 | $19,911 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2022 | $53,699 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2022 | $632,089 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $14,958 | | training reimbursement |
Merck Manufacturing (project 6) | Merck | North Carolina | state | 2022 | $167,242 | | training reimbursement |
Novartis Gene Therapies (frmly AveXis, Inc.) | Novartis | North Carolina | state | 2022 | $5,798 | | training reimbursement |
Pfizer (project 2) | Pfizer | North Carolina | state | 2022 | $153,219 | | training reimbursement |
Pfizer, Inc. (Chapel Hill) | Pfizer | North Carolina | state | 2022 | $20,984 | | training reimbursement |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2022 | $198,000 | | training reimbursement |
Baxalta Us Inc | Takeda Pharmaceutical | California | state | 2022 | $20,998 | | training reimbursement |
Novo Nordisk US Bio Production Inc | Novo Holdings A/S | New Hampshire | state | 2022 | undisclosed | | tax credit/rebate |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Pfizer | Pfizer | Tennessee | state | 2022 | undisclosed | | property tax abatement |
Novo Nordisk Research Center Seattle, Inc. | Novo Holdings A/S | Washington | state | 2022 | $2,645,382 | | tax credit/rebate |
Eli Lilly & Company | Eli Lilly | Indiana | state | 2022 | $293,100,000 | | MEGADEAL |
Bristol Myers Squibb Company | Bristol-Myers Squibb | Arizona | state | 2022 | $3,000,000 | | tax credit/rebate |
Regeneron Building D | Regeneron Pharmaceuticals | New York | local | 2022 | $2,171,758 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2022 | $336,050 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2022 | $226,608 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2022 | $169,333 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2022 | $133,565 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $116,856 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $113,118 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $75,893 | | tax credit/rebate |
Regeneron Phase II (aka LOOP Road project) | Regeneron Pharmaceuticals | New York | local | 2022 | $74,201 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $63,375 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2022 | $24,434 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2022 | $22,434 | | tax credit/rebate |
Amgen Inc. | Amgen | Ohio | state | 2021 | $15,000,000 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | multiple | 2021 | $107,700,000 | | MEGADEAL |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $77,030 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $19,850 | | training reimbursement |
Novartis Gene Therapies, Inc. (formerly AveXi | Novartis | Colorado | state | 2021 | $23,110 | | training reimbursement |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $47,739 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $110,366 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $302,558 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $581,555 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2021 | $22,214 | | tax credit/rebate |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | Maryland | state | 2021 | $1,461,100 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2021 | $41,307 | | tax credit/rebate |
Emergent Biosolutions, Inc. and Subsidiaries | Emergent BioSolutions | Maryland | state | 2021 | $55,509 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2021 | $31,602 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT | Johnson & Johnson | Maryland | state | 2021 | $29,953 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2021 | $603,374 | | tax credit/rebate |
MedImmune LLC | AstraZeneca | Maryland | state | 2021 | $794,270 | | tax credit/rebate |
Novo Nordisk Inc | Novo Holdings A/S | Maryland | state | 2021 | $3,194 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Pfizer | Maryland | state | 2021 | $29,497 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2021 | $100,088 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2021 | $49,887 | | tax credit/rebate |
Intervet Inc. | Merck | Kansas | state | 2021 | undisclosed | | tax credit/rebate |
Intervet Inc. | Merck | Kansas | state | 2021 | $1,000 | | training reimbursement |
Novo Nordisk Research Center Seattle, Inc. | Novo Holdings A/S | Washington | state | 2021 | $4,725,452 | | tax credit/rebate |
Omeros Corporation | Omeros Corp. | Washington | state | 2021 | $2,125,967 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $2,334,260 | | enterprise zone |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $1,031,751 | | tax credit/rebate |
Idexx Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2021 | $539,757 | | tax credit/rebate |
Idexx Distribution Inc | IDEXX Laboratories | Maine | state | 2021 | $275,737 | | tax credit/rebate |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2021 | $151,608 | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | local | 2021 | $7,000,000 | | grant |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $9,750,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $12,000,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $2,000,000 | | tax credit/rebate |
Elanco Us Inc. | Elanco Animal Health | Indiana | state | 2021 | $2,000,000 | | tax credit/rebate |
Amgen Inc. | Amgen | North Carolina | state | 2021 | $11,612,250 | | grant |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2021 | $9,997,500 | | grant |
Idexx Pharmaceuticals LLC | IDEXX Laboratories | Maine | state | 2021 | $1,773 | | property tax abatement |
Abbott Diagnostics Scarborough Inc | Abbott Laboratories | Maine | state | 2021 | $4,806 | | property tax abatement |
Idexx Labs, Inc. | IDEXX Laboratories | Maine | state | 2021 | $6,320 | | property tax abatement |
Idexx Operations Inc | IDEXX Laboratories | Maine | state | 2021 | $15,727 | | property tax abatement |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2021 | $167,626 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2021 | $795,000 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2021 | $6,481 | | tax credit/rebate |